- Home
- SABS vs IBIO Comparison
SABS vs IBIO Comparison
Compare SABS & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- IBIO
- Stock Information
- Founded
- SABS 2014
- IBIO 2008
- Country
- SABS United States
- IBIO United States
- Employees
- SABS N/A
- IBIO N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- SABS Health Care
- IBIO Health Care
- Exchange
- SABS Nasdaq
- IBIO Nasdaq
- Market Cap
- SABS 15.8M
- IBIO 15.9M
- IPO Year
- SABS N/A
- IBIO N/A
- Fundamental
- Price
- SABS $2.64
- IBIO $0.81
- Analyst Decision
- SABS Strong Buy
- IBIO Strong Buy
- Analyst Count
- SABS 5
- IBIO 3
- Target Price
- SABS $11.80
- IBIO $4.87
- AVG Volume (30 Days)
- SABS 35.3K
- IBIO 5.4M
- Earning Date
- SABS 08-07-2025
- IBIO 05-02-2025
- Dividend Yield
- SABS N/A
- IBIO N/A
- EPS Growth
- SABS N/A
- IBIO N/A
- EPS
- SABS N/A
- IBIO N/A
- Revenue
- SABS $377,835.00
- IBIO $375,000.00
- Revenue This Year
- SABS N/A
- IBIO $36.00
- Revenue Next Year
- SABS N/A
- IBIO N/A
- P/E Ratio
- SABS N/A
- IBIO N/A
- Revenue Growth
- SABS N/A
- IBIO 650.00
- 52 Week Low
- SABS $1.00
- IBIO $0.64
- 52 Week High
- SABS $5.01
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- SABS 77.22
- IBIO 47.34
- Support Level
- SABS $1.72
- IBIO $0.71
- Resistance Level
- SABS $2.72
- IBIO $0.87
- Average True Range (ATR)
- SABS 0.19
- IBIO 0.08
- MACD
- SABS 0.10
- IBIO 0.02
- Stochastic Oscillator
- SABS 91.89
- IBIO 37.39
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.